MCMedicalCodingSoftware
Free trial
3E0K305

3E0K305 — Introduction of Other Antineoplastic into Genitourinary Tract, Percutaneous Approach

Billable / specific codeICD-10-PCS

CMS abbreviated title: Introduce of Oth Antineoplastic into GU Tract, Perc Approach

How 3E0K305 is built

Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.

  1. 3SectionAdministration — What family of procedure this is
  2. EBody systemWhich system it acts on
  3. 0Root operationThe objective — the verb of the procedure
  4. KBody partThe specific site
  5. 3ApproachHow the site was reached
  6. 0DeviceWhat was left in place, if anything
  7. 5QualifierA further distinction where one applies

Codes near 3E0K305

In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.

  • 3E0J8HZIntroduction of Radioactive Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
  • 3E0J8KZIntroduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
  • 3E0J8NZIntroduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
  • 3E0J8SFIntroduction of Other Gas into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
  • 3E0J8TZIntroduction of Destructive Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
  • 3E0J8U0Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
  • 3E0J8U1Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
  • 3E0K304Introduction of Liquid Brachytherapy Radioisotope into Genitourinary Tract, Percutaneous Approach
  • 3E0K305Introduction of Other Antineoplastic into Genitourinary Tract, Percutaneous Approach
  • 3E0K30MIntroduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Percutaneous Approach
  • 3E0K328Introduction of Oxazolidinones into Genitourinary Tract, Percutaneous Approach
  • 3E0K329Introduction of Other Anti-infective into Genitourinary Tract, Percutaneous Approach
  • 3E0K33ZIntroduction of Anti-inflammatory into Genitourinary Tract, Percutaneous Approach
  • 3E0K36ZIntroduction of Nutritional Substance into Genitourinary Tract, Percutaneous Approach
  • 3E0K37ZIntroduction of Electrolytic and Water Balance Substance into Genitourinary Tract, Percutaneous Approach
  • 3E0K3BZIntroduction of Anesthetic Agent into Genitourinary Tract, Percutaneous Approach
  • 3E0K3GCIntroduction of Other Therapeutic Substance into Genitourinary Tract, Percutaneous Approach
ICD-10-PCSFY2026